Sera Prognostics (SERA) Non-Current Assets (2020 - 2026)
Sera Prognostics (SERA) posted Non-Current Assets of $43.8 million for Q1 2026, down 28.36% on a QoQ basis from $61.2 million in Q4 2025, and down 38.2% year-over-year from $70.9 million in Q1 2025.
Sera Prognostics (SERA) Non-Current Assets (2020 - 2026) Analysis & Trends
Sera Prognostics' Non-Current Assets history runs 7 years deep, the most recent figure standing at $43.8 million for Q1 2026.
- Quarterly Non-Current Assets fell 38.2% year-over-year to $43.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $239.6 million (up 52.51% YoY) and the FY2025 annual result came in at $61.2 million, up 144.9% from the prior year.
- Non-Current Assets was $43.8 million for Q1 2026 at Sera Prognostics, down from $61.2 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $71.0 million in Q2 2025 and bottomed at $17.0 million in Q2 2022.
- A 5-year average of $39.4 million and a median of $33.5 million in 2023 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets soared 359.77% — and 2026, when it slumped 38.2%.
- Sera Prognostics' Non-Current Assets stood at $26.2 million in 2022, then soared by 30.12% to $34.1 million in 2023, then slipped by 26.75% to $25.0 million in 2024, then soared by 144.9% to $61.2 million in 2025, then declined by 28.36% to $43.8 million in 2026.
- Business Quant data shows SERA's Non-Current Assets at $43.8 million in Q1 2026, $61.2 million in Q4 2025, and $63.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 28.59 Bn | 27.48 Bn | 750.30 Mn | 2.30 Bn |
| 7 | GE HealthCare Technologies | 28.53 Bn | 26.24 Bn | 1.98 Bn | 26.70 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | 6.35 Bn |
| 9 | Koninklijke Philips | 25.42 Bn | 22.30 Bn | 2.07 Bn | 20.47 Bn |
| 10 | Sera Prognostics | 107.55 Mn | 107.55 Mn | -28,000.00 | 43.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.82 Mn |
| Dec 31, 2025 | 61.16 Mn |
| Sep 30, 2025 | 63.63 Mn |
| Jun 30, 2025 | 70.96 Mn |
| Mar 31, 2025 | 70.90 Mn |
| Dec 31, 2024 | 24.98 Mn |
| Sep 30, 2024 | 27.89 Mn |
| Jun 30, 2024 | 33.32 Mn |
| Mar 31, 2024 | 36.04 Mn |
| Dec 31, 2023 | 34.10 Mn |
| Sep 30, 2023 | 42.51 Mn |
| Jun 30, 2023 | 32.25 Mn |
| Mar 31, 2023 | 33.50 Mn |
| Dec 31, 2022 | 26.20 Mn |
| Sep 30, 2022 | 25.72 Mn |
| Jun 30, 2022 | 17.01 Mn |
| Mar 31, 2022 | 25.40 Mn |
| Dec 31, 2021 | 36.78 Mn |
| Sep 30, 2021 | 31.35 Mn |
| Jun 30, 2021 | 3.70 Mn |